Original Research
Published on 08 Oct 2025
Addition of bevacizumab to gefitinib plus chemotherapy as first-line therapy in EGFR L858R mutate advanced non-small cell lung cancer patients
in Pharmacology of Anti-Cancer Drugs
- 661 views
Original Research
Published on 08 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 08 Oct 2025
in Peace and Democracy
Original Research
Published on 08 Oct 2025
in Work, Employment and Organizations
Opinion
Published on 08 Oct 2025
in Learning and Memory
Original Research
Published on 08 Oct 2025
in Digital Learning Innovations
Case Report
Published on 08 Oct 2025
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Published on 08 Oct 2025
in RNA Bioinformatics
Original Research
Published on 08 Oct 2025
in Intensive Care Medicine and Anesthesiology
Perspective
Published on 08 Oct 2025
in Healthcare Professions Education
Core Concept
Published on 08 Oct 2025
in Neuroscience and Psychology
Original Research
Published on 08 Oct 2025
in Nephrology
Original Research
Published on 08 Oct 2025
in Neurocognitive Aging and Behavior
Original Research
Published on 08 Oct 2025
in Media Psychology
Original Research
Published on 08 Oct 2025
in Breast Cancer
Original Research
Published on 08 Oct 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 08 Oct 2025
in Public Health Education and Promotion